A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant ARDEAPHARMA, a.s., against the decision of the State Institute for Drug Control from 6. 10. 2021, under the no: SUKLS36300/2021:
the decision is reversed and the proceedings are terminated.
A decision of the Ministry of Health regarding the appeal of the appelant ARDEAPHARMA, a.s. - the decision is reversed and the proceedings are terminated.
A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelants Dr. Falk Pharma GmbH and Ferring-Léčiva, a.s., against the decision of the State Institute for Drug Control from 11. 10. 2021, under the no: SUKLS174248/2020:
the decision is reversed and the proceedings are terminated.
A decision of the Ministry of Health regarding the appeal of the appelants Dr. Falk Pharma GmbH and Ferring-Léčiva, a.s. - the decision is reversed and the proceedings are terminated.
A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant HRA Pharma Rare Diseases, against the decision of the State Institute for Drug Control from 14. 10. 2021, under the no: SUKLS34108/2021:
the decision is reversed and the proceedings are terminated.
A decision of the Ministry of Health regarding the appeal of the appelant HRA Pharma Rare Diseases - the decision is reversed and the proceedings are terminated.
A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Egis Pharmaceuticals PLC, against the decision of the State Institute for Drug Control from 9. 9. 2020, under the no: SUKLS109905/2020:
the decision is reversed and the proceedings are terminated.
A decision of the Ministry of Health regarding the appeal of the appelant Egis Pharmaceuticals PLC - the decision is reversed and the proceedings are terminated.
A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelants Zentiva, k.s., Angelini Pharma Česká republika s.r.o., H. Lundbeck A/S, +pharma arzneimittel GmbH, Teva Pharmaceuticals CR, s.r.o., Actavis Group PTC ehf., Krka, tovarna zdravil, d.d. and Pfizer, spol. s r.o., against the decision of the State Institute for Drug Control from 30. 9. 2020, under the no: SUKLS115675/2009:
the decision is reversed and the proceedings are terminated.
A decision of the Ministry of Health regarding the appeal of the appelants Zentiva, k.s., Angelini Pharma Česká republika s.r.o., H. Lundbeck A/S, +pharma arzneimittel GmbH, Teva Pharmaceuticals...
